Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02858063
Other study ID # KALICOU2-0909
Secondary ID
Status Completed
Phase N/A
First received August 3, 2016
Last updated August 3, 2016
Start date January 2010
Est. completion date July 2012

Study information

Verified date August 2016
Source Centre Oscar Lambret
Contact n/a
Is FDA regulated No
Health authority France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santéFrance: Commission nationale de l'informatique et des libertésFrance: Conseil National de l'Ordre des Médecins
Study type Observational

Clinical Trial Summary

- Selection of patient and preparation of questionnaires

- Presentation of the study by the doctor

- Verbal consent of participants (patient and Partner)

- Delivery of booklets

- Response to documents (questionnaires and written consent) at home, send by mail


Description:

1. Before consultation :

Selection of patients according to inclusion criteria by persons in charge and preparation of inclusion file

2. During the consultation :

- Presentation of the study by the investigator

- The investigator signs the information note and give two file to the patient (1 for her and 1 for her Partner : both contains 1 information note signed by the investigator, 1 questionnaire and 2 stamped envelopes

- Finally, the investigator fill-in the medical form and send the original to the university (université de Lille 3)

3. At home :

- Signature of the information note and the participation consent form

- Patients and Partner responds to their questionnaire (including socio-demographique questionnaire)

- They send the documents thanks to stamped envelopes:

1. They send information note to the medical center

2. They send the questionnaires to the university


Recruitment information / eligibility

Status Completed
Enrollment 1045
Est. completion date July 2012
Est. primary completion date April 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- >18 years old (patient and partner)

- <45 years old (patient)

- Patient with a non metastatic breast cancer

- Patient treated or previously treated by chemotherapy

- Patient and her Partner live together for at least 6 months when they complete the questionnaires.

Exclusion Criteria:

- Patient or patner with psychiatric trouble

- Native language other than french

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Centre Oscar Lambret Université Lille 3

Outcome

Type Measure Description Time frame Safety issue
Primary psychometric validation of a questionnaire in Young patients and their partners 1 year No
Secondary compare convergent and or divergent dimensions with patients and theirs partners 1 year No
Secondary compare responses of participants according to traitement/ surveillance period 1 year No
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A